{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:42Z","timestamp":1707525342578},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,23]]},"DOI":"10.7759\/cureus.45831","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T03:50:20Z","timestamp":1695527420000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Rituximab Therapy for Skin Sclerosis and Myositis in a Patient With Systemic Sclerosis, Myositis and Sj\u00f6gren\u2019s Syndrome Associated With Autoimmune Polyendocrine Syndrome Type 2"],"prefix":"10.7759","author":[{"given":"Takako","family":"Saeki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Usuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye ES","year":"2018","unstructured":"Husebye ES, Anderson MS, K\u00e4mpe O. Autoimmune polyendocrine syndromes. N Engl J Med. 2018, 378:1132-1141. 10.1056\/NEJMra1713301","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Update on autoimmune polyendocrine syndromes (APS)","volume":"74","author":"Betterle C","year":"2003","unstructured":"Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. 2003, 74:9-33.","journal-title":"Acta Biomed"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228634","article-title":"A rare case of autoimmune polyglandular syndrome with Sj\u00f6gren's syndrome and primary hypoparathyroidism","volume":"12","author":"Iizuka K","year":"2019","unstructured":"Iizuka K, Mizuno M, Nonomura K, Yabe D. A rare case of autoimmune polyglandular syndrome with Sj\u00f6gren's syndrome and primary hypoparathyroidism. BMJ Case Rep. 2019, 12:e228634. 10.1136\/bcr-2018-228634","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/road040","article-title":"Role of rituximab in the treatment of systemic sclerosis: a literature review","author":"Yoshifuji H","year":"2023","unstructured":"Yoshifuji H, Yomono K, Yamano Y, Kondoh Y, Yasuoka H. Role of rituximab in the treatment of systemic sclerosis: a literature review. Mod Rheumatol. 2023, 040. 10.1093\/mr\/road040","journal-title":"Mod Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00107-7","article-title":"Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial","volume":"3","author":"Ebata S","year":"2021","unstructured":"Ebata S, Yoshizaki A, Oba K, et al.. Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial. Lancet Rheumatol. 2021, 3:e489-e497. 10.1016\/S2665-9913(21)00107-7","journal-title":"Lancet Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/186210-successful-rituximab-therapy-for-skin-sclerosis-and-myositis-in-a-patient-with-systemic-sclerosis-myositis-and-sjgrens-syndrome-associated-with-autoimmune-polyendocrine-syndrome-type-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:27Z","timestamp":1707509187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/186210-successful-rituximab-therapy-for-skin-sclerosis-and-myositis-in-a-patient-with-systemic-sclerosis-myositis-and-sjgrens-syndrome-associated-with-autoimmune-polyendocrine-syndrome-type-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.45831","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,23]]}}}